COVID-19 and the eye: Systemic and laboratory risk factors for retinopathy and detection of tear film SARS-CoV-2 RNA with a triplex RT-PCR assay.
Jessica G ShanthaTolulope FashinaVictoria StittleburgCasey RandlemanLaura WardMatt RegueiroDavid KrakowSusanne L LindermanCarolyn Drews-BotschRafi AhmedJesse WaggonerSteven YehPublished in: PloS one (2022)
Retinopathy was observed in 20% of patients hospitalized for COVID-19. Patients with retinopathy were more likely to be younger and have higher BMI than hospitalized patients without retinopathy. Tear film SARS-CoV-2 RNA was detected in 25% of patients. The relationship of obesity and age with retinopathy requires further investigation.
Keyphrases
- sars cov
- end stage renal disease
- ejection fraction
- coronavirus disease
- newly diagnosed
- respiratory syndrome coronavirus
- chronic kidney disease
- peritoneal dialysis
- type diabetes
- prognostic factors
- body mass index
- metabolic syndrome
- weight loss
- adipose tissue
- weight gain
- patient reported outcomes
- high throughput
- drug induced